Coloplast A/S (COLOb)

1,053.0
-0.5(-0.05%)
  • Volume:
    190,601
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    1,044.5 - 1,065.5
  • Type:Equity
  • Market:Denmark
  • ISIN:DK0060448595
  • S/N:198000000

COLOb Overview

Prev. Close
1,053.5
Day's Range
1,044.5-1,065.5
Revenue
19.43B
Open
1,058
52 wk Range
855.2-1,194
EPS
22.63
Volume
190,601
Market Cap
224.08B
Dividend (Yield)
19.00
(1.80%)
Average Vol. (3m)
196,659
P/E Ratio
46.47
Beta
0.62
1-Year Change
19.04%
Shares Outstanding
212,801,000
Next Earnings Date
Jan 25, 2022
What is your sentiment on Coloplast A/S?
or
Market is currently closed. Voting is open during market hours.

Coloplast A/S Company Profile

Employees
12728
Market
Denmark

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellStrong SellBuy
Technical IndicatorsStrong SellBuyStrong SellStrong SellStrong Buy
SummaryStrong SellNeutralStrong SellStrong SellStrong Buy
  • Har lige udbetalt udbytte, så nu kommer den til at stige frem til nytår.
    0
    • Do you really think so, Hans?Considering the P/E ratio, Coloplast is really very expensive: at the level of luxury shares. It would seem very difficult to increase its value. I would be very happy, anyway ........ What do you think?
      0
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.